NZM2:ETR
Novozymes A/S
€57.38
arrow_downward
-1.07%(-0.62) 1D
Oct 7, 10:38:01 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NZM2...
Open
€57.42
High
€57.42
Low
€57.38
Mkt. cap
172.22B
Avg. vol.
123.00
Volume
45.00
52-wk high
€61.96
52-wk low
€46.74
No. of employees
11K
Open
€57.42
High
€57.42
Low
€57.38
Mkt. cap
172.22B
Avg. vol.
123.00
Volume
45.00
52-wk high
€61.96
52-wk low
€46.74
No. of employees
11K
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
How Investors Are Reacting To Novonesis Stock As US Dairy Capacity Expands
AD HOC NEWS
·
2 days ago
Novonesis completes MicroBioGen deal as Novonesis stock gains 1.15 percent
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S